Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, Oregon.
Mod Pathol. 2024 Sep;37(9):100542. doi: 10.1016/j.modpat.2024.100542. Epub 2024 Jun 17.
Bone marrow aspiration (BMA) smear analysis is essential for diagnosis, treatment, and monitoring of a variety of benign and neoplastic hematological conditions. Currently, this analysis is performed by manual microscopy. We conducted a multicenter study to validate a computational microscopy approach with an artificial intelligence-driven decision support system. A total of 795 BMA specimens (615 Romanowsky-stained and 180 Prussian blue-stained) from patients with neoplastic and other clinical conditions were analyzed, comparing the performance of the Scopio Labs X100 Full Field BMA system (test method) with manual microscopy (reference method). The system provided an average of 1,385 ± 536 (range, 0-3,131) cells per specimen for analysis. An average of 39.98 ± 19.64 fields of view (range, 0-140) per specimen were selected by the system for analysis, of them 87% ± 21% (range, 0%-100%) were accepted by the qualified operators. These regions were included in an average of 17.62 ± 7.24 regions of interest (range, 1-50) per specimen. The efficiency, sensitivity, and specificity for primary and secondary marrow aspirate characteristics (maturation, morphology, and count assessment), as well as overall interuser agreement, were evaluated. The test method showed a high correlation with the reference method for comprehensive BMA evaluation, both on Romanowsky- (90.85% efficiency, 81.61% sensitivity, and 92.88% specificity) and Prussian blue-stained samples (90.0% efficiency, 81.94% sensitivity, and 93.38% specificity). The overall agreement between the test and reference methods for BMA assessment was 91.1%. For repeatability and reproducibility, all standard deviations and coefficients of variation values were below the predefined acceptance criteria both for discrete measurements (coefficient of variation below 20%) and differential measurements (SD below 5%). The high degree of correlation between the digital decision support system and manual microscopy demonstrates the potential of this system to provide a high-quality, accurate digital BMA analysis, expediting expert review and diagnosis of BMA specimens, with practical applications including remote BMA evaluation and possibly new opportunities for the research of normal and neoplastic hematopoiesis.
骨髓穿刺(BMA)涂片分析对于诊断、治疗和监测各种良性和恶性血液病至关重要。目前,这项分析是通过手动显微镜进行的。我们进行了一项多中心研究,以验证一种基于计算显微镜的方法和人工智能驱动的决策支持系统。总共分析了 795 例来自肿瘤和其他临床情况患者的 BMA 标本(615 例 Romanowsky 染色和 180 例普鲁士蓝染色),比较了 Scopio Labs X100 全视野 BMA 系统(测试方法)与手动显微镜(参考方法)的性能。该系统平均为每个标本提供 1,385 ± 536(范围,0-3,131)个细胞进行分析。系统平均为每个标本选择 39.98 ± 19.64 个视场(范围,0-140)进行分析,其中 87% ± 21%(范围,0%-100%)由合格操作员接受。这些区域平均包含在每个标本 17.62 ± 7.24 个感兴趣区域(范围,1-50)中。评估了主要和次要骨髓抽吸特征(成熟度、形态和计数评估)的效率、敏感性和特异性,以及整体用户间一致性。测试方法与参考方法在 Romanowsky-(综合 BMA 评估的效率为 90.85%、敏感性为 81.61%、特异性为 92.88%)和普鲁士蓝染色样本(效率为 90.0%、敏感性为 81.94%、特异性为 93.38%)上均具有高度相关性。BMA 评估的测试和参考方法之间的总体一致性为 91.1%。对于重复性和再现性,离散测量(变异系数低于 20%)和差分测量(SD 低于 5%)的所有标准差和变异系数值均低于预设的可接受标准。数字决策支持系统与手动显微镜之间的高度相关性表明,该系统有可能提供高质量、准确的数字 BMA 分析,加速 BMA 标本的专家审查和诊断,实际应用包括远程 BMA 评估,并且可能为正常和恶性造血的研究带来新的机会。